SCHEMBL21394650

SCHEMBL21394650

O=C(Nc1ccc(Cc2ccc(F)c(F)c2)cn1)c1ccnnc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.41
WNT3A P56704 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
KCNQ3 O43525 2/20 0.41
KCNQ2 O43526 2/20 0.41
MAOB P27338 1/20 0.41
F10 P00742 4/20 0.41
DEGS1 O15121 1/20 0.40
PPARG P37231 1/20 0.39
KDM4E B2RXH2 1/20 0.39
KLKB1 P03952 1/20 0.39
CXCR2 P25025 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21395019 0.88 PARP1 (0.53) PARP1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21394654 0.87 WNT3A (0.44) PARP1WNT3ASMN1; SMN2NPC1RAB9A
SCHEMBL21394854 0.86 WNT3A (0.52) WNT3ASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL29359193 0.86 WNT3A (0.52) WNT3ASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21394732 0.81 KCNQ3 (0.48) PARP1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21395182 0.81 GSK3B (0.44) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL21394645 0.80 DEGS1 (0.42) ALDH1A1KCNQ3KCNQ2MAOBF10
SCHEMBL21394997 0.80 KCNQ3 (0.57) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL21395118 0.80 KCNQ3 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL21394718 0.80 NPC1 (0.42) PARP1SMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198026-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed